{
  "experiment_id": "fbd911c6c1e3ae065060ac881b9093bf",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "9dc5c284f909400a12e111d9ec8ba4e5",
  "model_id": "us.deepseek.r1-v1:0",
  "system_instructions": "### Temperature\n\n1.0",
  "temperature": 1.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-11-15T05:50:03.568659",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"Sanger sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```Okay, let's tackle this metadata curation task. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace any broad terms with the more specific ones from the Target Schema.\n\nFirst, looking at the diagnosis. The input says \"Neurofibromatosis\". The Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\" but not just \"Neurofibromatosis\". Since \"Neurofibromatosis\" is a general term and the schema specifies \"type 1\", I should replace it with \"Neurofibromatosis type 1\".\n\nNext, the assay is \"DNA sequencing\". The Target Schema's assay enum has several sequencing methods like \"Sanger sequencing\", \"whole exome sequencing\", etc. \"DNA sequencing\" is too broad. The closest specific term here would be \"Sanger sequencing\" as a common method, unless there's more context. Since the input doesn't specify, \"Sanger sequencing\" is a safe choice from the provided options.\n\nFor tumorType, the input is \"Neurofibroma\". The Target Schema's tumorType enum includes \"Neurofibroma\" as an option. Wait, but there are other subtypes like \"Cutaneous Neurofibroma\" or \"Plexiform Neurofibroma\". However, the original input is just \"Neurofibroma\", and since that exact term is present in the enum, maybe it's acceptable. But wait, looking again, the schema has \"Neurofibroma\" as an option. So unless the original data needs a more specific type, but since the input is general, we can leave it as \"Neurofibroma\".\n\nWait, but the user said to narrow broad synonyms. If \"Neurofibroma\" is already in the target schema, then no change is needed. But maybe the example in the Target Schema has more specific terms. Let me check again. The tumorType enum includes \"Neurofibroma\", \"Atypical Neurofibroma\", \"Cellular Neurofibroma\", etc. Since the input is \"Neurofibroma\", which is a valid enum value, perhaps it's correct as is. However, the user might want to check if there's a more specific term. But without additional context, \"Neurofibroma\" is the best match. So no change here.\n\nWait, but the original input's tumorType is \"Neurofibroma\", which is present in the Target Schema's tumorType enum. So that's correct. So no need to change that.\n\nSo the corrected data would be:\n\ndiagnosis: \"Neurofibromatosis type 1\"\n\nassay: \"Sanger sequencing\"\n\ntumorType: \"Neurofibroma\"\n\nWait, but the assay \"DNA sequencing\" could also be \"whole genome sequencing\" or \"targeted sequencing\". However, the Target Schema's assay enum includes \"Sanger sequencing\", \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", etc. The term \"DNA sequencing\" is too broad. The user needs to pick the most specific term from the enum. Since the input is generic, maybe \"targeted sequencing\" is an option, but \"Sanger sequencing\" is a specific method. Alternatively, \"genotyping\" is another possibility, but \"genotyping\" is different. The Target Schema's assay enum includes \"Sanger sequencing\" as an exact term. Since \"DNA sequencing\" is a general term, and the Target Schema doesn't have a \"DNA sequencing\" option, the correct replacement would be \"Sanger sequencing\" as the most common specific method, unless there's a more appropriate term. Alternatively, \"next generation targeted sequencing\" is also in the assay enum, but without knowing the exact method, \"Sanger sequencing\" is a safe default. Alternatively, maybe \"genotyping\" is not correct here. The input says \"DNA sequencing\", which is a general term. The Target Schema has \"Sanger sequencing\", \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", \"next generation targeted sequencing\", etc. Since the input is generic, perhaps the best approach is to use \"Sanger sequencing\" as the most basic specific method. Alternatively, if the data is from a next-gen sequencing approach, but without context, \"Sanger sequencing\" is a common choice. So I'll go with \"Sanger sequencing\" for the assay.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2284,
            "outputTokens": 928,
            "totalTokens": 3212
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "d9221209-875b-4030-8606-974a64937fef",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:48:55 GMT",
                "content-type": "application/json",
                "content-length": "4432",
                "connection": "keep-alive",
                "x-amzn-requestid": "d9221209-875b-4030-8606-974a64937fef"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"Sanger sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata curation task. The user provided an input with three fields: diagnosis, assay, and tumorType. My job is to replace any broad terms with the more specific ones from the Target Schema.\n\nFirst, looking at the diagnosis. The input says \"Neurofibromatosis\". The Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\" but not just \"Neurofibromatosis\". Since \"Neurofibromatosis\" is a general term and the schema specifies \"type 1\", I should replace it with \"Neurofibromatosis type 1\".\n\nNext, the assay is \"DNA sequencing\". The Target Schema's assay enum has several sequencing methods like \"Sanger sequencing\", \"whole exome sequencing\", etc. \"DNA sequencing\" is too broad. The closest specific term here would be \"Sanger sequencing\" as a common method, unless there's more context. Since the input doesn't specify, \"Sanger sequencing\" is a safe choice from the provided options.\n\nFor tumorType, the input is \"Neurofibroma\". The Target Schema's tumorType enum includes \"Neurofibroma\" as an option. Wait, but there are other subtypes like \"Cutaneous Neurofibroma\" or \"Plexiform Neurofibroma\". However, the original input is just \"Neurofibroma\", and since that exact term is present in the enum, maybe it's acceptable. But wait, looking again, the schema has \"Neurofibroma\" as an option. So unless the original data needs a more specific type, but since the input is general, we can leave it as \"Neurofibroma\".\n\nWait, but the user said to narrow broad synonyms. If \"Neurofibroma\" is already in the target schema, then no change is needed. But maybe the example in the Target Schema has more specific terms. Let me check again. The tumorType enum includes \"Neurofibroma\", \"Atypical Neurofibroma\", \"Cellular Neurofibroma\", etc. Since the input is \"Neurofibroma\", which is a valid enum value, perhaps it's correct as is. However, the user might want to check if there's a more specific term. But without additional context, \"Neurofibroma\" is the best match. So no change here.\n\nWait, but the original input's tumorType is \"Neurofibroma\", which is present in the Target Schema's tumorType enum. So that's correct. So no need to change that.\n\nSo the corrected data would be:\n\ndiagnosis: \"Neurofibromatosis type 1\"\n\nassay: \"Sanger sequencing\"\n\ntumorType: \"Neurofibroma\"\n\nWait, but the assay \"DNA sequencing\" could also be \"whole genome sequencing\" or \"targeted sequencing\". However, the Target Schema's assay enum includes \"Sanger sequencing\", \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", etc. The term \"DNA sequencing\" is too broad. The user needs to pick the most specific term from the enum. Since the input is generic, maybe \"targeted sequencing\" is an option, but \"Sanger sequencing\" is a specific method. Alternatively, \"genotyping\" is another possibility, but \"genotyping\" is different. The Target Schema's assay enum includes \"Sanger sequencing\" as an exact term. Since \"DNA sequencing\" is a general term, and the Target Schema doesn't have a \"DNA sequencing\" option, the correct replacement would be \"Sanger sequencing\" as the most common specific method, unless there's a more appropriate term. Alternatively, \"next generation targeted sequencing\" is also in the assay enum, but without knowing the exact method, \"Sanger sequencing\" is a safe default. Alternatively, maybe \"genotyping\" is not correct here. The input says \"DNA sequencing\", which is a general term. The Target Schema has \"Sanger sequencing\", \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", \"next generation targeted sequencing\", etc. Since the input is generic, perhaps the best approach is to use \"Sanger sequencing\" as the most basic specific method. Alternatively, if the data is from a next-gen sequencing approach, but without context, \"Sanger sequencing\" is a common choice. So I'll go with \"Sanger sequencing\" for the assay.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2284,
              "outputTokens": 928,
              "totalTokens": 3212
            },
            "metrics": {
              "latencyMs": 8509
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2284,
          "output_tokens": 928,
          "total_tokens": 3212
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```Okay, let's tackle this problem. The user wants me to correct the input metadata by replacing broad terms with specific ones from the Target Schema.\n\nFirst, looking at the diagnosis field. The input is \"NF\". In the Target Schema's diagnosis enum, there's \"Neurofibromatosis type 1\". \"NF\" is a common abbreviation for Neurofibromatosis, so I should replace \"NF\" with \"Neurofibromatosis type 1\". But wait, there's also \"NF2-related schwannomatosis\". However, the input is just \"NF\", which is more general. Since the schema doesn't have a general \"NF\" but has \"Neurofibromatosis type 1\", that's the most specific match here. So diagnosis becomes \"Neurofibromatosis type 1\".\n\nNext, the assay is \"exome sequencing\". The Target Schema's assay enum includes \"whole exome sequencing\". The input \"exome sequencing\" is a broad term, so replacing it with the exact value \"whole exome sequencing\" makes sense. That's the correct narrowing here.\n\nFor tumorType, the input is \"sarcoma\". The schema's tumorType enum has \"Fibrosarcoma\" and \"Sarcoma\". Since \"Sarcoma\" is present as an exact term, but the input is the general \"sarcoma\", but the schema allows \"Sarcoma\" (capitalized), so we should use \"Sarcoma\" as the exact value. Wait, the input is lowercase, but the schema's enum has \"Sarcoma\" with a capital S. The instruction says to use exact values, so we should capitalize it. So tumorType becomes \"Sarcoma\".\n\nDouble-checking all the enums to ensure the replacements are exact. Yes, \"Neurofibromatosis type 1\", \"whole exome sequencing\", and \"Sarcoma\" are all present in their respective enums. No other terms seem to fit better. So the corrected JSON should have those values.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2281,
            "outputTokens": 446,
            "totalTokens": 2727
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "b94933e8-55b0-4319-b80e-f262421b014f",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:48:59 GMT",
                "content-type": "application/json",
                "content-length": "2130",
                "connection": "keep-alive",
                "x-amzn-requestid": "b94933e8-55b0-4319-b80e-f262421b014f"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this problem. The user wants me to correct the input metadata by replacing broad terms with specific ones from the Target Schema.\n\nFirst, looking at the diagnosis field. The input is \"NF\". In the Target Schema's diagnosis enum, there's \"Neurofibromatosis type 1\". \"NF\" is a common abbreviation for Neurofibromatosis, so I should replace \"NF\" with \"Neurofibromatosis type 1\". But wait, there's also \"NF2-related schwannomatosis\". However, the input is just \"NF\", which is more general. Since the schema doesn't have a general \"NF\" but has \"Neurofibromatosis type 1\", that's the most specific match here. So diagnosis becomes \"Neurofibromatosis type 1\".\n\nNext, the assay is \"exome sequencing\". The Target Schema's assay enum includes \"whole exome sequencing\". The input \"exome sequencing\" is a broad term, so replacing it with the exact value \"whole exome sequencing\" makes sense. That's the correct narrowing here.\n\nFor tumorType, the input is \"sarcoma\". The schema's tumorType enum has \"Fibrosarcoma\" and \"Sarcoma\". Since \"Sarcoma\" is present as an exact term, but the input is the general \"sarcoma\", but the schema allows \"Sarcoma\" (capitalized), so we should use \"Sarcoma\" as the exact value. Wait, the input is lowercase, but the schema's enum has \"Sarcoma\" with a capital S. The instruction says to use exact values, so we should capitalize it. So tumorType becomes \"Sarcoma\".\n\nDouble-checking all the enums to ensure the replacements are exact. Yes, \"Neurofibromatosis type 1\", \"whole exome sequencing\", and \"Sarcoma\" are all present in their respective enums. No other terms seem to fit better. So the corrected JSON should have those values.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2281,
              "outputTokens": 446,
              "totalTokens": 2727
            },
            "metrics": {
              "latencyMs": 4365
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2281,
          "output_tokens": 446,
          "total_tokens": 2727
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```Okay, let's tackle this metadata curation task. The user wants me to replace broad synonyms in the input data with more specific terms from the Target Schema. First, I need to look at each field in the input and see what needs to be adjusted.\n\nStarting with the \"diagnosis\" field. The input has \"Neurofibromatoses\". The Target Schema's enum includes \"Neurofibromatosis type 1\" and others. \"Neurofibromatoses\" is a plural form, but the closest specific term here is \"Neurofibromatosis type 1\". Wait, but maybe \"Schwannomatosis\" is another possibility? The schema has several schwannomatosis-related terms. However, \"Neurofibromatoses\" generally refers to a group that includes NF1, NF2, and schwannomatosis. Since the input is a general term, but the Target Schema doesn't have a general \"Neurofibromatoses\" option, I need to check if there's a more specific term. The user might be referring to NF1 here, but without more context, maybe \"Schwannomatosis-NOS\" (Not Otherwise Specified) or \"Schwannomatosis-NEC\" (Not Elsewhere Classified) could be options. Wait, the original input is \"Neurofibromatoses\", which is plural. The Target Schema has \"Neurofibromatosis type 1\" as a singular. Since the input is a broad term, and the Target Schema doesn't have a plural form, perhaps the correct replacement is \"Neurofibromatosis type 1\" if that's the most common, but maybe \"Schwannomatosis-NOS\" if it's a schwannomatosis case. Hmm, this is a bit ambiguous. Alternatively, maybe the correct term is \"Schwannomatosis\" if the original diagnosis is a type of schwannomatosis. But the input is \"Neurofibromatoses\", which is a broader category. Since the Target Schema doesn't have that exact term, I need to pick the most appropriate specific term. Wait, the Target Schema's diagnosis enum includes \"Schwannomatosis-NOS\" and \"Schwannomatosis-NEC\" for cases that are not otherwise specified. However, \"Neurofibromatoses\" is a group that includes NF1, NF2, and schwannomatosis. Since the input is using the plural, which isn't in the schema, perhaps the best approach is to check if there's a more general term. Wait, the schema has \"Schwannomatosis\" as a term. But \"Neurofibromatoses\" isn't directly mapped. Maybe the user intended to refer to NF1, which is a common type. Alternatively, if the original data is a general term, but the schema requires a specific one, perhaps \"Schwannomatosis-NOS\" is the best fit here. Alternatively, maybe \"Neurofibromatosis type 1\" is the correct mapping. But without more context, it's hard to tell. However, the Target Schema's diagnosis enum does include \"Neurofibromatosis type 1\", so perhaps that's the correct replacement. Wait, but \"Neurofibromatoses\" is plural, which could imply multiple types, but the schema doesn't have a plural. So maybe the correct term is \"Neurofibromatosis type 1\" as the most common type. Alternatively, if the original data is a general term that's not specific, maybe \"Schwannomatosis-NOS\" is better. Hmm, this is a bit tricky. Let me check the Target Schema again. The diagnosis enum includes \"Schwannomatosis\", \"Schwannomatosis-NOS\", \"Schwannomatosis-NEC\", \"Neurofibromatosis type 1\", \"Noonan Syndrome\", etc. Since \"Neurofibromatoses\" is a group that includes NF1, NF2, and schwannomatosis, but the input is using the plural, which isn't in the schema, perhaps the best approach is to map it to \"Neurofibromatosis type 1\" as the most common form. Alternatively, if the data is about schwannomatosis, then \"Schwannomatosis-NOS\". But without additional context, I'll have to make an educated guess. Let's proceed with \"Neurofibromatosis type 1\" for the diagnosis.\n\nNext, the \"assay\" field. The input is \"assay by high throughput sequencer\". The Target Schema's assay enum includes \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", \"next generation targeted sequencing\", etc. The term \"high throughput sequencer\" is a general term, so I need to find the specific assay that matches. The closest terms are \"whole exome sequencing\", \"whole genome sequencing\", or \"next generation targeted sequencing\". Since the input is a general \"high throughput sequencer\", perhaps \"whole genome sequencing\" is the most appropriate, as it's a common high-throughput method. Alternatively, \"next generation targeted sequencing\" if it's targeted. But without more context, \"whole genome sequencing\" might be the best fit. However, the Target Schema's assay enum also has \"next generation targeted sequencing\" as an option. Wait, the input says \"assay by high throughput sequencer\", which is a method, but the assay names in the schema are more specific. The term \"high throughput sequencer\" could refer to various sequencing assays. The schema has \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", \"next generation targeted sequencing\", \"RNA-seq\", etc. Since the input is vague, perhaps the best match is \"whole genome sequencing\" as a common high-throughput assay. Alternatively, \"next generation targeted sequencing\" if it's targeted. But without more info, maybe \"whole genome sequencing\" is the safest choice. Alternatively, \"targeted sequencing\" if it's targeted. Hmm. The user's instruction says to use the exact terms from the Target Schema. The input's assay is \"assay by high throughput sequencer\", which is a general term. The Target Schema doesn't have a \"high throughput sequencing\" term. The closest would be \"whole exome sequencing\", \"whole genome sequencing\", \"RNA-seq\", etc. Since the input is a general term, perhaps \"whole genome sequencing\" is the best fit here. So I'll replace \"assay by high throughput sequencer\" with \"whole genome sequencing\".\n\nNow the \"tumorType\" field. The input is \"Nerve Sheath Neoplasm\". The Target Schema's tumorType enum includes \"Malignant Peripheral Nerve Sheath Tumor\", \"Schwannoma\", \"Neurofibroma\", etc. \"Nerve Sheath Neoplasm\" is a broad term. The specific terms in the schema include \"Malignant Peripheral Nerve Sheath Tumor\" (MPNST), \"Schwannoma\", \"Neurofibroma\", etc. Since \"Nerve Sheath Neoplasm\" is a general category, but the schema requires a specific type, the best fit would be \"Malignant Peripheral Nerve Sheath Tumor\" if it's malignant. However, if it's benign, \"Schwannoma\" or \"Neurofibroma\" might be better. But without more context, \"Malignant Peripheral Nerve Sheath Tumor\" is a specific term in the schema. Alternatively, if the tumor is a schwannoma, then \"Schwannoma\". But the input is \"Nerve Sheath Neoplasm\", which is a broader term. The Target Schema's tumorType enum has \"Schwannoma\" and \"Malignant Peripheral Nerve Sheath Tumor\". Since \"Nerve Sheath Neoplasm\" is a general term, perhaps the best approach is to use \"Malignant Peripheral Nerve Sheath Tumor\" as a specific type. Alternatively, if it's benign, \"Schwannoma\" or \"Neurofibroma\". But without additional info, maybe \"Malignant Peripheral Nerve Sheath Tumor\" is the most precise term available in the schema. Alternatively, the schema also has \"NF1-Associated Tumor\" or \"NF2-Associated Tumor\", but those are more about association. Since \"Nerve Sheath Neoplasm\" is a type of tumor arising from the nerve sheath, the specific terms are MPNST, Schwannoma, or Neurofibroma. Given that \"Malignant Peripheral Nerve Sheath Tumor\" is a specific type of nerve sheath neoplasm, that's likely the correct replacement here. So I'll map \"Nerve Sheath Neoplasm\" to \"Malignant Peripheral Nerve Sheath Tumor\".\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2292,
            "outputTokens": 1824,
            "totalTokens": 4116
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "b4bb079b-0791-4dbd-93a7-364c06ebdb72",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:49:14 GMT",
                "content-type": "application/json",
                "content-length": "8062",
                "connection": "keep-alive",
                "x-amzn-requestid": "b4bb079b-0791-4dbd-93a7-364c06ebdb72"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata curation task. The user wants me to replace broad synonyms in the input data with more specific terms from the Target Schema. First, I need to look at each field in the input and see what needs to be adjusted.\n\nStarting with the \"diagnosis\" field. The input has \"Neurofibromatoses\". The Target Schema's enum includes \"Neurofibromatosis type 1\" and others. \"Neurofibromatoses\" is a plural form, but the closest specific term here is \"Neurofibromatosis type 1\". Wait, but maybe \"Schwannomatosis\" is another possibility? The schema has several schwannomatosis-related terms. However, \"Neurofibromatoses\" generally refers to a group that includes NF1, NF2, and schwannomatosis. Since the input is a general term, but the Target Schema doesn't have a general \"Neurofibromatoses\" option, I need to check if there's a more specific term. The user might be referring to NF1 here, but without more context, maybe \"Schwannomatosis-NOS\" (Not Otherwise Specified) or \"Schwannomatosis-NEC\" (Not Elsewhere Classified) could be options. Wait, the original input is \"Neurofibromatoses\", which is plural. The Target Schema has \"Neurofibromatosis type 1\" as a singular. Since the input is a broad term, and the Target Schema doesn't have a plural form, perhaps the correct replacement is \"Neurofibromatosis type 1\" if that's the most common, but maybe \"Schwannomatosis-NOS\" if it's a schwannomatosis case. Hmm, this is a bit ambiguous. Alternatively, maybe the correct term is \"Schwannomatosis\" if the original diagnosis is a type of schwannomatosis. But the input is \"Neurofibromatoses\", which is a broader category. Since the Target Schema doesn't have that exact term, I need to pick the most appropriate specific term. Wait, the Target Schema's diagnosis enum includes \"Schwannomatosis-NOS\" and \"Schwannomatosis-NEC\" for cases that are not otherwise specified. However, \"Neurofibromatoses\" is a group that includes NF1, NF2, and schwannomatosis. Since the input is using the plural, which isn't in the schema, perhaps the best approach is to check if there's a more general term. Wait, the schema has \"Schwannomatosis\" as a term. But \"Neurofibromatoses\" isn't directly mapped. Maybe the user intended to refer to NF1, which is a common type. Alternatively, if the original data is a general term, but the schema requires a specific one, perhaps \"Schwannomatosis-NOS\" is the best fit here. Alternatively, maybe \"Neurofibromatosis type 1\" is the correct mapping. But without more context, it's hard to tell. However, the Target Schema's diagnosis enum does include \"Neurofibromatosis type 1\", so perhaps that's the correct replacement. Wait, but \"Neurofibromatoses\" is plural, which could imply multiple types, but the schema doesn't have a plural. So maybe the correct term is \"Neurofibromatosis type 1\" as the most common type. Alternatively, if the original data is a general term that's not specific, maybe \"Schwannomatosis-NOS\" is better. Hmm, this is a bit tricky. Let me check the Target Schema again. The diagnosis enum includes \"Schwannomatosis\", \"Schwannomatosis-NOS\", \"Schwannomatosis-NEC\", \"Neurofibromatosis type 1\", \"Noonan Syndrome\", etc. Since \"Neurofibromatoses\" is a group that includes NF1, NF2, and schwannomatosis, but the input is using the plural, which isn't in the schema, perhaps the best approach is to map it to \"Neurofibromatosis type 1\" as the most common form. Alternatively, if the data is about schwannomatosis, then \"Schwannomatosis-NOS\". But without additional context, I'll have to make an educated guess. Let's proceed with \"Neurofibromatosis type 1\" for the diagnosis.\n\nNext, the \"assay\" field. The input is \"assay by high throughput sequencer\". The Target Schema's assay enum includes \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", \"next generation targeted sequencing\", etc. The term \"high throughput sequencer\" is a general term, so I need to find the specific assay that matches. The closest terms are \"whole exome sequencing\", \"whole genome sequencing\", or \"next generation targeted sequencing\". Since the input is a general \"high throughput sequencer\", perhaps \"whole genome sequencing\" is the most appropriate, as it's a common high-throughput method. Alternatively, \"next generation targeted sequencing\" if it's targeted. But without more context, \"whole genome sequencing\" might be the best fit. However, the Target Schema's assay enum also has \"next generation targeted sequencing\" as an option. Wait, the input says \"assay by high throughput sequencer\", which is a method, but the assay names in the schema are more specific. The term \"high throughput sequencer\" could refer to various sequencing assays. The schema has \"whole exome sequencing\", \"whole genome sequencing\", \"targeted sequencing\", \"next generation targeted sequencing\", \"RNA-seq\", etc. Since the input is vague, perhaps the best match is \"whole genome sequencing\" as a common high-throughput assay. Alternatively, \"next generation targeted sequencing\" if it's targeted. But without more info, maybe \"whole genome sequencing\" is the safest choice. Alternatively, \"targeted sequencing\" if it's targeted. Hmm. The user's instruction says to use the exact terms from the Target Schema. The input's assay is \"assay by high throughput sequencer\", which is a general term. The Target Schema doesn't have a \"high throughput sequencing\" term. The closest would be \"whole exome sequencing\", \"whole genome sequencing\", \"RNA-seq\", etc. Since the input is a general term, perhaps \"whole genome sequencing\" is the best fit here. So I'll replace \"assay by high throughput sequencer\" with \"whole genome sequencing\".\n\nNow the \"tumorType\" field. The input is \"Nerve Sheath Neoplasm\". The Target Schema's tumorType enum includes \"Malignant Peripheral Nerve Sheath Tumor\", \"Schwannoma\", \"Neurofibroma\", etc. \"Nerve Sheath Neoplasm\" is a broad term. The specific terms in the schema include \"Malignant Peripheral Nerve Sheath Tumor\" (MPNST), \"Schwannoma\", \"Neurofibroma\", etc. Since \"Nerve Sheath Neoplasm\" is a general category, but the schema requires a specific type, the best fit would be \"Malignant Peripheral Nerve Sheath Tumor\" if it's malignant. However, if it's benign, \"Schwannoma\" or \"Neurofibroma\" might be better. But without more context, \"Malignant Peripheral Nerve Sheath Tumor\" is a specific term in the schema. Alternatively, if the tumor is a schwannoma, then \"Schwannoma\". But the input is \"Nerve Sheath Neoplasm\", which is a broader term. The Target Schema's tumorType enum has \"Schwannoma\" and \"Malignant Peripheral Nerve Sheath Tumor\". Since \"Nerve Sheath Neoplasm\" is a general term, perhaps the best approach is to use \"Malignant Peripheral Nerve Sheath Tumor\" as a specific type. Alternatively, if it's benign, \"Schwannoma\" or \"Neurofibroma\". But without additional info, maybe \"Malignant Peripheral Nerve Sheath Tumor\" is the most precise term available in the schema. Alternatively, the schema also has \"NF1-Associated Tumor\" or \"NF2-Associated Tumor\", but those are more about association. Since \"Nerve Sheath Neoplasm\" is a type of tumor arising from the nerve sheath, the specific terms are MPNST, Schwannoma, or Neurofibroma. Given that \"Malignant Peripheral Nerve Sheath Tumor\" is a specific type of nerve sheath neoplasm, that's likely the correct replacement here. So I'll map \"Nerve Sheath Neoplasm\" to \"Malignant Peripheral Nerve Sheath Tumor\".\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2292,
              "outputTokens": 1824,
              "totalTokens": 4116
            },
            "metrics": {
              "latencyMs": 14312
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2292,
          "output_tokens": 1824,
          "total_tokens": 4116
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```Okay, let's tackle this metadata curation task. The user wants me to replace broad synonyms with more specific terms from the Target Schema. Let's start with the diagnosis field. The input is \"neurocutaneous syndrome\". Looking at the Target Schema's diagnosis enum, I need to find the closest match. Neurofibromatosis type 1 is a neurocutaneous disorder, so that's a possible replacement. But wait, there's also \"Schwannomatosis\" and others. However, \"neurocutaneous syndrome\" is a broad term that includes several conditions like NF1, NF2, etc. Since the Target Schema doesn't have a general \"neurocutaneous syndrome\" option, but does have \"Neurofibromatosis type 1\", which is a specific type, maybe that's the best fit. But wait, the user might have intended a different specific condition. However, without more context, \"Neurofibromatosis type 1\" is a valid narrowing.\n\nNext, the assay is \"spectroscopy\". The Target Schema has \"FTIR spectroscopy\" and \"dynamic light scattering\", but \"FTIR spectroscopy\" is the exact term. Since the input is just \"spectroscopy\", which is too broad, replacing it with \"FTIR spectroscopy\" would be appropriate. But wait, maybe the user meant another type? The Target Schema also has \"mass spectrometry\", but that's different. Since FTIR is a specific spectroscopy method listed, that's the correct choice here.\n\nThe tumorType is \"unknown\". The Target Schema's tumorType enum includes \"Unknown\" with a capital U. The input has it lowercase, so we need to correct it to match the exact enum value \"Unknown\".\n\nSo the corrected JSON should have diagnosis as \"Neurofibromatosis type 1\", assay as \"FTIR spectroscopy\", and tumorType as \"Unknown\". Let me double-check the enums again to make sure. Yes, \"Neurofibromatosis type 1\" is in the diagnosis enum, \"FTIR spectroscopy\" is under assay, and \"Unknown\" is in tumorType. All exact matches. That should be the correct output.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2281,
            "outputTokens": 471,
            "totalTokens": 2752
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "809809da-2789-4b74-bb49-76f9542df382",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:49:18 GMT",
                "content-type": "application/json",
                "content-length": "2351",
                "connection": "keep-alive",
                "x-amzn-requestid": "809809da-2789-4b74-bb49-76f9542df382"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata curation task. The user wants me to replace broad synonyms with more specific terms from the Target Schema. Let's start with the diagnosis field. The input is \"neurocutaneous syndrome\". Looking at the Target Schema's diagnosis enum, I need to find the closest match. Neurofibromatosis type 1 is a neurocutaneous disorder, so that's a possible replacement. But wait, there's also \"Schwannomatosis\" and others. However, \"neurocutaneous syndrome\" is a broad term that includes several conditions like NF1, NF2, etc. Since the Target Schema doesn't have a general \"neurocutaneous syndrome\" option, but does have \"Neurofibromatosis type 1\", which is a specific type, maybe that's the best fit. But wait, the user might have intended a different specific condition. However, without more context, \"Neurofibromatosis type 1\" is a valid narrowing.\n\nNext, the assay is \"spectroscopy\". The Target Schema has \"FTIR spectroscopy\" and \"dynamic light scattering\", but \"FTIR spectroscopy\" is the exact term. Since the input is just \"spectroscopy\", which is too broad, replacing it with \"FTIR spectroscopy\" would be appropriate. But wait, maybe the user meant another type? The Target Schema also has \"mass spectrometry\", but that's different. Since FTIR is a specific spectroscopy method listed, that's the correct choice here.\n\nThe tumorType is \"unknown\". The Target Schema's tumorType enum includes \"Unknown\" with a capital U. The input has it lowercase, so we need to correct it to match the exact enum value \"Unknown\".\n\nSo the corrected JSON should have diagnosis as \"Neurofibromatosis type 1\", assay as \"FTIR spectroscopy\", and tumorType as \"Unknown\". Let me double-check the enums again to make sure. Yes, \"Neurofibromatosis type 1\" is in the diagnosis enum, \"FTIR spectroscopy\" is under assay, and \"Unknown\" is in tumorType. All exact matches. That should be the correct output.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2281,
              "outputTokens": 471,
              "totalTokens": 2752
            },
            "metrics": {
              "latencyMs": 4166
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2281,
          "output_tokens": 471,
          "total_tokens": 2752
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```Okay, let's tackle this problem. The user wants me to correct the input metadata by replacing broad terms with more specific ones from the Target Schema. The input has three fields: diagnosis, assay, and tumorType.\n\nFirst, looking at the diagnosis. The input is \"Not Applicable\". Checking the Target Schema's diagnosis enum, \"Not Applicable\" is already an exact value there. So no change needed here.\n\nNext, the assay is \"immunoassay\". The Target Schema's assay enum includes \"immunoassay\" as an option. Since it's already present, I don't need to modify this either.\n\nNow, the tumorType is \"neurofibroma\". The Target Schema's tumorType enum has several options related to neurofibroma. The input uses the general term \"neurofibroma\", but the schema has more specific types like \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\", etc. However, the original input doesn't specify the subtype. The Target Schema does include \"Neurofibroma\" as an enum value. Wait, checking the list: yes, \"Neurofibroma\" is there. So if the input is the general term and the schema allows it, maybe it's acceptable. But wait, the user wants to narrow broad synonyms. If \"neurofibroma\" in the input is the general term, but the schema has more specific terms, should we replace it? But the input's value is exactly \"neurofibroma\", which is present in the Target Schema's tumorType enum. So unless there's a more specific term required, we can leave it as is. However, looking at the schema's tumorType enum, \"Neurofibroma\" is listed, so unless the input's \"neurofibroma\" (lowercase 'n') is a typo, but in the Target Schema, it's \"Neurofibroma\" with a capital 'N'. Wait, the input JSON has \"neurofibroma\" in lowercase, but the Target Schema's enum entries are all capitalized. For example, \"Neurofibroma\" is in the enum. So the input's value is \"neurofibroma\" (lowercase), which doesn't exactly match the schema's \"Neurofibroma\" (capitalized). Therefore, I need to correct the case to match the exact value. So the tumorType should be \"Neurofibroma\" with a capital 'N' to match the enum.\n\nWait, but JSON keys and values are case-sensitive. The Target Schema's tumorType enum includes \"Neurofibroma\" with a capital 'N', so the input's \"neurofibroma\" is lowercase and thus doesn't match. Therefore, the correction here is to capitalize the first letter to \"Neurofibroma\".\n\nSo the corrected JSON would have \"Neurofibroma\" for tumorType, while the other fields remain the same since they already match the Target Schema's enums exactly (assuming \"Not Applicable\" and \"immunoassay\" are correctly capitalized as per the schema). Checking the diagnosis enum: \"Not Applicable\" is present, so the input's \"Not Applicable\" matches exactly. The assay's \"immunoassay\" is in the enum as \"immunoassay\" (lowercase), so that's correct. Wait, no: looking at the assay enum, the entries are case-sensitive. For example, \"2D AlamarBlue absorbance\" starts with uppercase, but \"immunoassay\" is all lowercase in the Target Schema. Wait, checking the assay enum list: \"immunoassay\" is listed as lowercase. So the input's \"immunoassay\" is correct. The tumorType's \"neurofibroma\" in the input is lowercase, but the Target Schema's enum has \"Neurofibroma\" with a capital 'N'. Therefore, the tumorType needs to be corrected to \"Neurofibroma\".\n\nSo the final corrected JSON would have \"Neurofibroma\" for tumorType, and the other fields remain as they are.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2284,
            "outputTokens": 853,
            "totalTokens": 3137
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "c9a0aa1e-9c60-4367-ad66-4140332a215e",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:49:25 GMT",
                "content-type": "application/json",
                "content-length": "3880",
                "connection": "keep-alive",
                "x-amzn-requestid": "c9a0aa1e-9c60-4367-ad66-4140332a215e"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this problem. The user wants me to correct the input metadata by replacing broad terms with more specific ones from the Target Schema. The input has three fields: diagnosis, assay, and tumorType.\n\nFirst, looking at the diagnosis. The input is \"Not Applicable\". Checking the Target Schema's diagnosis enum, \"Not Applicable\" is already an exact value there. So no change needed here.\n\nNext, the assay is \"immunoassay\". The Target Schema's assay enum includes \"immunoassay\" as an option. Since it's already present, I don't need to modify this either.\n\nNow, the tumorType is \"neurofibroma\". The Target Schema's tumorType enum has several options related to neurofibroma. The input uses the general term \"neurofibroma\", but the schema has more specific types like \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\", etc. However, the original input doesn't specify the subtype. The Target Schema does include \"Neurofibroma\" as an enum value. Wait, checking the list: yes, \"Neurofibroma\" is there. So if the input is the general term and the schema allows it, maybe it's acceptable. But wait, the user wants to narrow broad synonyms. If \"neurofibroma\" in the input is the general term, but the schema has more specific terms, should we replace it? But the input's value is exactly \"neurofibroma\", which is present in the Target Schema's tumorType enum. So unless there's a more specific term required, we can leave it as is. However, looking at the schema's tumorType enum, \"Neurofibroma\" is listed, so unless the input's \"neurofibroma\" (lowercase 'n') is a typo, but in the Target Schema, it's \"Neurofibroma\" with a capital 'N'. Wait, the input JSON has \"neurofibroma\" in lowercase, but the Target Schema's enum entries are all capitalized. For example, \"Neurofibroma\" is in the enum. So the input's value is \"neurofibroma\" (lowercase), which doesn't exactly match the schema's \"Neurofibroma\" (capitalized). Therefore, I need to correct the case to match the exact value. So the tumorType should be \"Neurofibroma\" with a capital 'N' to match the enum.\n\nWait, but JSON keys and values are case-sensitive. The Target Schema's tumorType enum includes \"Neurofibroma\" with a capital 'N', so the input's \"neurofibroma\" is lowercase and thus doesn't match. Therefore, the correction here is to capitalize the first letter to \"Neurofibroma\".\n\nSo the corrected JSON would have \"Neurofibroma\" for tumorType, while the other fields remain the same since they already match the Target Schema's enums exactly (assuming \"Not Applicable\" and \"immunoassay\" are correctly capitalized as per the schema). Checking the diagnosis enum: \"Not Applicable\" is present, so the input's \"Not Applicable\" matches exactly. The assay's \"immunoassay\" is in the enum as \"immunoassay\" (lowercase), so that's correct. Wait, no: looking at the assay enum, the entries are case-sensitive. For example, \"2D AlamarBlue absorbance\" starts with uppercase, but \"immunoassay\" is all lowercase in the Target Schema. Wait, checking the assay enum list: \"immunoassay\" is listed as lowercase. So the input's \"immunoassay\" is correct. The tumorType's \"neurofibroma\" in the input is lowercase, but the Target Schema's enum has \"Neurofibroma\" with a capital 'N'. Therefore, the tumorType needs to be corrected to \"Neurofibroma\".\n\nSo the final corrected JSON would have \"Neurofibroma\" for tumorType, and the other fields remain as they are.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2284,
              "outputTokens": 853,
              "totalTokens": 3137
            },
            "metrics": {
              "latencyMs": 7564
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2284,
          "output_tokens": 853,
          "total_tokens": 3137
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"high content screen\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```Okay, let's tackle this metadata curation task. The user wants me to replace broad terms with specific ones from the Target Schema. Let's start with the diagnosis field. The input is \"neurofibromatosis\". The Target Schema's diagnosis enum has \"Neurofibromatosis type 1\" and \"Schwannomatosis\" among others. Since \"neurofibromatosis\" is a general term, but the specific type here isn't specified, maybe the correct term is \"Neurofibromatosis type 1\" as the most common type. But wait, the schema also has \"Schwannomatosis\" and others. However, the input doesn't specify type 1 or type 2. Hmm, but the Target Schema doesn't have a general \"neurofibromatosis\" entry. The closest is \"Neurofibromatosis type 1\". Alternatively, if the original data is too vague, maybe \"Schwannomatosis-NOS\" (not otherwise specified) or \"Schwannomatosis-NEC\" (not elsewhere classified)? Wait, no, because \"neurofibromatosis\" typically refers to NF1 or NF2. Since the schema has \"Neurofibromatosis type 1\" as an option, and the input is just the general term, perhaps the correct choice is \"Neurofibromatosis type 1\" assuming that's the most common. But maybe the user expects a more precise term. Wait, the Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\", which is specific. The input \"neurofibromatosis\" is broad, so the correct narrowing would be to the specific type if possible. However, without more context, maybe the correct term is \"Neurofibromatosis type 1\" as the default? Or is there a more appropriate term? Let me check the schema again. The options are: \"Neurofibromatosis type 1\", \"Noonan Syndrome\", \"Schwannomatosis\", etc. Since the input is \"neurofibromatosis\", which is a general term, but the schema doesn't have a general term, the correct approach is to map to the most specific possible. If the original data doesn't specify the type, perhaps \"Schwannomatosis-NOS\" or \"Neurofibromatosis type 1\"? Wait, \"Schwannomatosis\" is a different condition. Neurofibromatosis type 1 (NF1) and type 2 (NF2) are distinct. The Target Schema has \"Neurofibromatosis type 1\" and \"NF2-related schwannomatosis\". Since the input is \"neurofibromatosis\", which is a broader term, but the schema doesn't have a general \"Neurofibromatosis\" entry, the correct term would be \"Neurofibromatosis type 1\" if that's the most common, but without more info, maybe it's better to use \"Schwannomatosis-NOS\"? Wait, no. Schwannomatosis is a different condition. The user's input is \"neurofibromatosis\", which is typically NF1 or NF2. Since the Target Schema has \"Neurofibromatosis type 1\" as an enum value, and the input is the general term, perhaps the correct mapping is to \"Neurofibromatosis type 1\". Alternatively, if the data is ambiguous, maybe \"Unknown\"? But the user wants to narrow, not make it unknown. So I think \"Neurofibromatosis type 1\" is the best fit here.\n\nNext, the assay is \"plate based reporter assay\". Looking at the Target Schema's assay enum, I need to find a more specific term. The options include things like \"FLIPR high-throughput cellular screening\", \"cell viability assay\", \"cell proliferation\", etc. \"Plate based reporter assay\" is a general term. The closest specific term might be \"FLIPR high-throughput cellular screening\" if it's a calcium flux assay, but maybe \"cell viability assay\" or \"cell proliferation assay\". Alternatively, \"high content screen\"? Wait, the assay enum has \"FLIPR high-throughput cellular screening\" which is a plate-based assay using FLIPR technology. If the original assay is a reporter gene assay, maybe \"FLIPR\" is not the right term. Alternatively, \"cell viability assay\" or \"cell proliferation\" could be possibilities. But the Target Schema doesn't have a \"reporter assay\" entry. The closest might be \"FLIPR high-throughput cellular screening\" if it's a fluorescence-based plate reader assay. Alternatively, \"electrochemiluminescence\" or \"luciferase reporter assay\", but those aren't in the schema. Hmm. The Target Schema's assay enum includes \"FLIPR high-throughput cellular screening\", which is a specific type of plate-based assay. If the original is a general plate-based reporter, maybe \"FLIPR\" is not the exact match. Alternatively, \"cell viability assay\" or \"cell proliferation assay\" if the reporter is measuring viability or proliferation. Alternatively, \"electrochemiluminescence\" if that's the detection method. But without more context, it's hard. The user's instruction is to use the exact terms from the schema. Since \"plate based reporter assay\" isn't in the schema, I need to find the closest match. Maybe \"cell viability assay\" is too broad. Alternatively, \"high content screen\" if it's imaging-based. Alternatively, \"fluorescence microscopy assay\" if it uses fluorescence. But the term \"reporter assay\" might be a gene reporter, which could be part of a \"cell painting\" assay? Not sure. Alternatively, \"combination screen\" or \"compound screen\" if it's a drug screening. Alternatively, \"electrochemiluminescence\" if that's the detection method. Alternatively, \"luciferase\" isn't in the schema. Hmm. The Target Schema's assay enum has \"FLIPR high-throughput cellular screening\" which is a plate-based assay for calcium flux. If the original assay is a different type of reporter (e.g., luciferase), but the schema doesn't have that, perhaps the best is to use \"cell viability assay\" if it's measuring cell viability, or \"cell proliferation\" if it's measuring proliferation. Alternatively, \"electrochemiluminescence\" if that's the detection method. Alternatively, \"ELISA\" if it's an enzyme-linked assay. But \"plate based reporter assay\" is too vague. Since the exact term isn't present, maybe the best is to look for the closest term. Alternatively, \"high content screen\" which is a broad term but is in the schema. Wait, the schema has \"high content screen\" as an option. That might be appropriate if it's a plate-based imaging assay. Alternatively, \"cell painting\" is a specific type of high-content screening. But without more info, maybe \"high content screen\" is the best fit. Alternatively, \"cell viability assay\" if it's measuring viability. But the user's input is \"reporter assay\", which typically involves a reporter gene (like luciferase or GFP). Since the schema doesn't have a specific term for that, perhaps the best is to use \"high content screen\" if it's imaging-based, or \"cell viability assay\" if it's a viability readout. Alternatively, \"electrochemiluminescence\" if that's the detection method. Alternatively, \"fluorescence microscopy assay\" if using fluorescence. But without more context, it's challenging. The safest bet might be to check the Target Schema's assay enum again. Let me look again. The assay enum includes \"FLIPR high-throughput cellular screening\", \"cell viability assay\", \"cell proliferation\", \"electrochemiluminescence\", \"ELISA\", \"high content screen\", etc. Since \"plate based reporter assay\" is a general term, and the exact term isn't present, the best approach is to map to the most appropriate specific term. If the reporter assay is measuring cell viability, then \"cell viability assay\". If it's measuring gene expression, maybe \"RNA-seq\" but that's not a reporter assay. Alternatively, \"luciferase\" isn't listed. Hmm. Maybe \"electrochemiluminescence\" is the detection method used in some reporter assays. Alternatively, \"ELISA\" if it's an enzyme-linked assay. But I'm not sure. Since the user requires exact terms, and \"plate based reporter assay\" isn't present, perhaps the best is to use \"high content screen\" as a broader but more specific term than the input. Alternatively, \"cell viability assay\" if that's the purpose. But without more context, it's hard. Let's assume that \"high content screen\" is the best fit here, as it's a plate-based assay that uses imaging, which is common in reporter assays. So I'll go with \"high content screen\".\n\nFinally, the tumorType is \"benign neurofibroma\". The Target Schema's tumorType enum has \"Atypical Neurofibroma\", \"Cellular Neurofibroma\", \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Neurofibroma\", \"Plexiform Neurofibroma\", etc. The input is \"benign neurofibroma\", which is a general term. The schema has \"Neurofibroma\" as a general term, but also more specific types. Since \"benign\" could imply a non-atypical, non-plexiform type. The schema has \"Localized Neurofibroma\" which is a benign, circumscribed neurofibroma. Alternatively, \"Cutaneous Neurofibroma\" if it's skin-based. But the input just says \"benign\", which is a general descriptor. The Target Schema's tumorType enum includes \"Neurofibroma\" as a general term. Since \"benign neurofibroma\" is a type of neurofibroma, and the schema has \"Neurofibroma\" as an option, perhaps that's the correct mapping. The more specific terms like \"Localized\" or \"Cutaneous\" would require additional info. So replacing \"benign neurofibroma\" with \"Neurofibroma\" as the specific term from the schema.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2288,
            "outputTokens": 2142,
            "totalTokens": 4430
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "06fa87de-0a4e-4171-a157-bca714693b51",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:49:42 GMT",
                "content-type": "application/json",
                "content-length": "9545",
                "connection": "keep-alive",
                "x-amzn-requestid": "06fa87de-0a4e-4171-a157-bca714693b51"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"high content screen\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata curation task. The user wants me to replace broad terms with specific ones from the Target Schema. Let's start with the diagnosis field. The input is \"neurofibromatosis\". The Target Schema's diagnosis enum has \"Neurofibromatosis type 1\" and \"Schwannomatosis\" among others. Since \"neurofibromatosis\" is a general term, but the specific type here isn't specified, maybe the correct term is \"Neurofibromatosis type 1\" as the most common type. But wait, the schema also has \"Schwannomatosis\" and others. However, the input doesn't specify type 1 or type 2. Hmm, but the Target Schema doesn't have a general \"neurofibromatosis\" entry. The closest is \"Neurofibromatosis type 1\". Alternatively, if the original data is too vague, maybe \"Schwannomatosis-NOS\" (not otherwise specified) or \"Schwannomatosis-NEC\" (not elsewhere classified)? Wait, no, because \"neurofibromatosis\" typically refers to NF1 or NF2. Since the schema has \"Neurofibromatosis type 1\" as an option, and the input is just the general term, perhaps the correct choice is \"Neurofibromatosis type 1\" assuming that's the most common. But maybe the user expects a more precise term. Wait, the Target Schema's diagnosis enum includes \"Neurofibromatosis type 1\", which is specific. The input \"neurofibromatosis\" is broad, so the correct narrowing would be to the specific type if possible. However, without more context, maybe the correct term is \"Neurofibromatosis type 1\" as the default? Or is there a more appropriate term? Let me check the schema again. The options are: \"Neurofibromatosis type 1\", \"Noonan Syndrome\", \"Schwannomatosis\", etc. Since the input is \"neurofibromatosis\", which is a general term, but the schema doesn't have a general term, the correct approach is to map to the most specific possible. If the original data doesn't specify the type, perhaps \"Schwannomatosis-NOS\" or \"Neurofibromatosis type 1\"? Wait, \"Schwannomatosis\" is a different condition. Neurofibromatosis type 1 (NF1) and type 2 (NF2) are distinct. The Target Schema has \"Neurofibromatosis type 1\" and \"NF2-related schwannomatosis\". Since the input is \"neurofibromatosis\", which is a broader term, but the schema doesn't have a general \"Neurofibromatosis\" entry, the correct term would be \"Neurofibromatosis type 1\" if that's the most common, but without more info, maybe it's better to use \"Schwannomatosis-NOS\"? Wait, no. Schwannomatosis is a different condition. The user's input is \"neurofibromatosis\", which is typically NF1 or NF2. Since the Target Schema has \"Neurofibromatosis type 1\" as an enum value, and the input is the general term, perhaps the correct mapping is to \"Neurofibromatosis type 1\". Alternatively, if the data is ambiguous, maybe \"Unknown\"? But the user wants to narrow, not make it unknown. So I think \"Neurofibromatosis type 1\" is the best fit here.\n\nNext, the assay is \"plate based reporter assay\". Looking at the Target Schema's assay enum, I need to find a more specific term. The options include things like \"FLIPR high-throughput cellular screening\", \"cell viability assay\", \"cell proliferation\", etc. \"Plate based reporter assay\" is a general term. The closest specific term might be \"FLIPR high-throughput cellular screening\" if it's a calcium flux assay, but maybe \"cell viability assay\" or \"cell proliferation assay\". Alternatively, \"high content screen\"? Wait, the assay enum has \"FLIPR high-throughput cellular screening\" which is a plate-based assay using FLIPR technology. If the original assay is a reporter gene assay, maybe \"FLIPR\" is not the right term. Alternatively, \"cell viability assay\" or \"cell proliferation\" could be possibilities. But the Target Schema doesn't have a \"reporter assay\" entry. The closest might be \"FLIPR high-throughput cellular screening\" if it's a fluorescence-based plate reader assay. Alternatively, \"electrochemiluminescence\" or \"luciferase reporter assay\", but those aren't in the schema. Hmm. The Target Schema's assay enum includes \"FLIPR high-throughput cellular screening\", which is a specific type of plate-based assay. If the original is a general plate-based reporter, maybe \"FLIPR\" is not the exact match. Alternatively, \"cell viability assay\" or \"cell proliferation assay\" if the reporter is measuring viability or proliferation. Alternatively, \"electrochemiluminescence\" if that's the detection method. But without more context, it's hard. The user's instruction is to use the exact terms from the schema. Since \"plate based reporter assay\" isn't in the schema, I need to find the closest match. Maybe \"cell viability assay\" is too broad. Alternatively, \"high content screen\" if it's imaging-based. Alternatively, \"fluorescence microscopy assay\" if it uses fluorescence. But the term \"reporter assay\" might be a gene reporter, which could be part of a \"cell painting\" assay? Not sure. Alternatively, \"combination screen\" or \"compound screen\" if it's a drug screening. Alternatively, \"electrochemiluminescence\" if that's the detection method. Alternatively, \"luciferase\" isn't in the schema. Hmm. The Target Schema's assay enum has \"FLIPR high-throughput cellular screening\" which is a plate-based assay for calcium flux. If the original assay is a different type of reporter (e.g., luciferase), but the schema doesn't have that, perhaps the best is to use \"cell viability assay\" if it's measuring cell viability, or \"cell proliferation\" if it's measuring proliferation. Alternatively, \"electrochemiluminescence\" if that's the detection method. Alternatively, \"ELISA\" if it's an enzyme-linked assay. But \"plate based reporter assay\" is too vague. Since the exact term isn't present, maybe the best is to look for the closest term. Alternatively, \"high content screen\" which is a broad term but is in the schema. Wait, the schema has \"high content screen\" as an option. That might be appropriate if it's a plate-based imaging assay. Alternatively, \"cell painting\" is a specific type of high-content screening. But without more info, maybe \"high content screen\" is the best fit. Alternatively, \"cell viability assay\" if it's measuring viability. But the user's input is \"reporter assay\", which typically involves a reporter gene (like luciferase or GFP). Since the schema doesn't have a specific term for that, perhaps the best is to use \"high content screen\" if it's imaging-based, or \"cell viability assay\" if it's a viability readout. Alternatively, \"electrochemiluminescence\" if that's the detection method. Alternatively, \"fluorescence microscopy assay\" if using fluorescence. But without more context, it's challenging. The safest bet might be to check the Target Schema's assay enum again. Let me look again. The assay enum includes \"FLIPR high-throughput cellular screening\", \"cell viability assay\", \"cell proliferation\", \"electrochemiluminescence\", \"ELISA\", \"high content screen\", etc. Since \"plate based reporter assay\" is a general term, and the exact term isn't present, the best approach is to map to the most appropriate specific term. If the reporter assay is measuring cell viability, then \"cell viability assay\". If it's measuring gene expression, maybe \"RNA-seq\" but that's not a reporter assay. Alternatively, \"luciferase\" isn't listed. Hmm. Maybe \"electrochemiluminescence\" is the detection method used in some reporter assays. Alternatively, \"ELISA\" if it's an enzyme-linked assay. But I'm not sure. Since the user requires exact terms, and \"plate based reporter assay\" isn't present, perhaps the best is to use \"high content screen\" as a broader but more specific term than the input. Alternatively, \"cell viability assay\" if that's the purpose. But without more context, it's hard. Let's assume that \"high content screen\" is the best fit here, as it's a plate-based assay that uses imaging, which is common in reporter assays. So I'll go with \"high content screen\".\n\nFinally, the tumorType is \"benign neurofibroma\". The Target Schema's tumorType enum has \"Atypical Neurofibroma\", \"Cellular Neurofibroma\", \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Neurofibroma\", \"Plexiform Neurofibroma\", etc. The input is \"benign neurofibroma\", which is a general term. The schema has \"Neurofibroma\" as a general term, but also more specific types. Since \"benign\" could imply a non-atypical, non-plexiform type. The schema has \"Localized Neurofibroma\" which is a benign, circumscribed neurofibroma. Alternatively, \"Cutaneous Neurofibroma\" if it's skin-based. But the input just says \"benign\", which is a general descriptor. The Target Schema's tumorType enum includes \"Neurofibroma\" as a general term. Since \"benign neurofibroma\" is a type of neurofibroma, and the schema has \"Neurofibroma\" as an option, perhaps that's the correct mapping. The more specific terms like \"Localized\" or \"Cutaneous\" would require additional info. So replacing \"benign neurofibroma\" with \"Neurofibroma\" as the specific term from the schema.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2288,
              "outputTokens": 2142,
              "totalTokens": 4430
            },
            "metrics": {
              "latencyMs": 16600
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2288,
          "output_tokens": 2142,
          "total_tokens": 4430
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Step-by-Step Explanation:**\n1. **Diagnosis:** \"RASopathy\" was mapped to \"Noonan Syndrome\" since this is the only RASopathy-related term available in the target schema's diagnosis enum.\n2. **Assay:** \"immunoassay\" was retained as it exactly matches an allowed value in the assay enum.\n3. **TumorType:** \"NFIB\" (a transcription factor gene) was mapped to \"Unknown\" since this gene designation does not correspond to any tumor type in the controlled terminology.Okay, let's tackle this metadata curation task. The user wants me to replace broad synonyms with more specific terms from the Target Schema. Let's start with the diagnosis field. The input is \"RASopathy\". Looking at the Target Schema's diagnosis enum, I don't see \"RASopathy\" listed. However, \"Noonan Syndrome\" is part of the RASopathy group. So, \"RASopathy\" should be narrowed to \"Noonan Syndrome\".\n\nNext, the assay is \"immunoassay\". The Target Schema's assay enum includes \"immunoassay\" as an exact term. Since it's already present and matches exactly, no change is needed here.\n\nNow, the tumorType is \"NFIB\". Checking the tumorType enum, \"NFIB\" isn't listed. The closest options are \"NF1-Associated Tumor\" or \"NF2-Associated Tumor\". Since NFIB is a gene, but the schema doesn't have a specific entry for it, maybe \"Not Applicable\" or \"Unknown\" would be appropriate. However, \"NFIB\" might be a typo for \"NF1\" or \"NF2\". If \"NFIB\" refers to a tumor associated with NF1, then \"NF1-Associated Tumor\" would be correct. But without more context, it's safer to use \"Unknown\" as per the schema options.\n\nSo, the corrected entries would be diagnosis: \"Noonan Syndrome\", assay remains \"immunoassay\", and tumorType becomes \"Unknown\".\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2283,
            "outputTokens": 452,
            "totalTokens": 2735
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "ca4dad36-1283-4f42-9fb1-0d2789f295ec",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:49:46 GMT",
                "content-type": "application/json",
                "content-length": "2135",
                "connection": "keep-alive",
                "x-amzn-requestid": "ca4dad36-1283-4f42-9fb1-0d2789f295ec"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Step-by-Step Explanation:**\n1. **Diagnosis:** \"RASopathy\" was mapped to \"Noonan Syndrome\" since this is the only RASopathy-related term available in the target schema's diagnosis enum.\n2. **Assay:** \"immunoassay\" was retained as it exactly matches an allowed value in the assay enum.\n3. **TumorType:** \"NFIB\" (a transcription factor gene) was mapped to \"Unknown\" since this gene designation does not correspond to any tumor type in the controlled terminology."
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata curation task. The user wants me to replace broad synonyms with more specific terms from the Target Schema. Let's start with the diagnosis field. The input is \"RASopathy\". Looking at the Target Schema's diagnosis enum, I don't see \"RASopathy\" listed. However, \"Noonan Syndrome\" is part of the RASopathy group. So, \"RASopathy\" should be narrowed to \"Noonan Syndrome\".\n\nNext, the assay is \"immunoassay\". The Target Schema's assay enum includes \"immunoassay\" as an exact term. Since it's already present and matches exactly, no change is needed here.\n\nNow, the tumorType is \"NFIB\". Checking the tumorType enum, \"NFIB\" isn't listed. The closest options are \"NF1-Associated Tumor\" or \"NF2-Associated Tumor\". Since NFIB is a gene, but the schema doesn't have a specific entry for it, maybe \"Not Applicable\" or \"Unknown\" would be appropriate. However, \"NFIB\" might be a typo for \"NF1\" or \"NF2\". If \"NFIB\" refers to a tumor associated with NF1, then \"NF1-Associated Tumor\" would be correct. But without more context, it's safer to use \"Unknown\" as per the schema options.\n\nSo, the corrected entries would be diagnosis: \"Noonan Syndrome\", assay remains \"immunoassay\", and tumorType becomes \"Unknown\".\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2283,
              "outputTokens": 452,
              "totalTokens": 2735
            },
            "metrics": {
              "latencyMs": 4353
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2283,
          "output_tokens": 452,
          "total_tokens": 2735
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```Okay, let's tackle this problem. The user wants me to correct the metadata entries by replacing broad terms with specific ones from the Target Schema. The input has three fields: diagnosis, assay, and tumorType.\n\nFirst, the diagnosis is \"NF\". In the Target Schema's diagnosis enum, there are options like \"Neurofibromatosis type 1\" and \"NF2-related schwannomatosis\". \"NF\" is a common abbreviation for Neurofibromatosis, but I need to check which specific term matches. Since \"Neurofibromatosis type 1\" is an option, that's likely the correct replacement for \"NF\".\n\nNext, the assay is \"medical imaging\". Looking at the assay enum, there are several imaging-related terms. The closest matches are \"conventional MRI\", \"functional MRI\", \"structural MRI\", etc. However, \"medical imaging\" is too broad. The Target Schema doesn't have a general term for medical imaging, so I need to find the most specific. Since the input is vague, maybe \"conventional MRI\" is a safe choice, but wait, there's also \"3D imaging\" and \"ultrasound\". Hmm, but \"conventional MRI\" is part of the enum. Alternatively, if \"medical imaging\" refers to MRI, then \"conventional MRI\" would fit. Let's go with that.\n\nFor tumorType, the input is \"unknown\". The Target Schema's tumorType enum includes \"Unknown\" (with a capital U). The input has it lowercase, so I need to correct it to match the exact value \"Unknown\".\n\nSo the corrected JSON should be:\n- diagnosis: \"Neurofibromatosis type 1\"\n- assay: \"conventional MRI\"\n- tumorType: \"Unknown\"\n\nWait, but let me double-check the assay. The Target Schema's assay enum includes \"conventional MRI\", \"Magnetization-Prepared Rapid Gradient Echo MRI\", \"diffusion MRI\", etc. Since \"medical imaging\" is a general term, and the user wants the most specific, but without more context, \"conventional MRI\" is the best fit. Alternatively, if \"medical imaging\" is a broader term not listed, but according to the Target Schema, \"conventional MRI\" is an allowed value. So yes, that's correct.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2279,
            "outputTokens": 512,
            "totalTokens": 2791
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "1a3380f5-7f0e-439f-9f9e-8a48696daafc",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:49:51 GMT",
                "content-type": "application/json",
                "content-length": "2458",
                "connection": "keep-alive",
                "x-amzn-requestid": "1a3380f5-7f0e-439f-9f9e-8a48696daafc"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this problem. The user wants me to correct the metadata entries by replacing broad terms with specific ones from the Target Schema. The input has three fields: diagnosis, assay, and tumorType.\n\nFirst, the diagnosis is \"NF\". In the Target Schema's diagnosis enum, there are options like \"Neurofibromatosis type 1\" and \"NF2-related schwannomatosis\". \"NF\" is a common abbreviation for Neurofibromatosis, but I need to check which specific term matches. Since \"Neurofibromatosis type 1\" is an option, that's likely the correct replacement for \"NF\".\n\nNext, the assay is \"medical imaging\". Looking at the assay enum, there are several imaging-related terms. The closest matches are \"conventional MRI\", \"functional MRI\", \"structural MRI\", etc. However, \"medical imaging\" is too broad. The Target Schema doesn't have a general term for medical imaging, so I need to find the most specific. Since the input is vague, maybe \"conventional MRI\" is a safe choice, but wait, there's also \"3D imaging\" and \"ultrasound\". Hmm, but \"conventional MRI\" is part of the enum. Alternatively, if \"medical imaging\" refers to MRI, then \"conventional MRI\" would fit. Let's go with that.\n\nFor tumorType, the input is \"unknown\". The Target Schema's tumorType enum includes \"Unknown\" (with a capital U). The input has it lowercase, so I need to correct it to match the exact value \"Unknown\".\n\nSo the corrected JSON should be:\n- diagnosis: \"Neurofibromatosis type 1\"\n- assay: \"conventional MRI\"\n- tumorType: \"Unknown\"\n\nWait, but let me double-check the assay. The Target Schema's assay enum includes \"conventional MRI\", \"Magnetization-Prepared Rapid Gradient Echo MRI\", \"diffusion MRI\", etc. Since \"medical imaging\" is a general term, and the user wants the most specific, but without more context, \"conventional MRI\" is the best fit. Alternatively, if \"medical imaging\" is a broader term not listed, but according to the Target Schema, \"conventional MRI\" is an allowed value. So yes, that's correct.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2279,
              "outputTokens": 512,
              "totalTokens": 2791
            },
            "metrics": {
              "latencyMs": 4718
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2279,
          "output_tokens": 512,
          "total_tokens": 2791
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis-NOS\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```Okay, let's tackle this metadata curation task. The user wants me to replace broad synonyms with more specific terms from the Target Schema.\n\nFirst, looking at the diagnosis field. The input is \"neurocristopathy\". I need to check the enum list for diagnosis. The term \"neurocristopathy\" isn't there, but I know that schwannomatosis is a type of neurocristopathy. The closest terms in the schema are \"Schwannomatosis-NOS\" (Not Otherwise Specified) or \"Schwannomatosis-NEC\" (Not Elsewhere Classified). Since the input is a general term, \"Schwannomatosis-NOS\" might be the best fit here as a non-specific category.\n\nNext, the assay is \"transcriptomics\". The Target Schema's assay enum includes \"transcriptomics\", so that's already an exact match. No change needed here.\n\nFor tumorType, the input is \"neurolemmoma\". I recall that neurolemmoma is another name for schwannoma. Checking the tumorType enum, \"Schwannoma\" is listed. So replacing \"neurolemmoma\" with \"Schwannoma\" would be correct.\n\nI need to ensure all replacements use the exact terms from the schema. Let me double-check each enum list again to confirm. Diagnosis: \"Schwannomatosis-NOS\" is present. Assay: \"transcriptomics\" is there. TumorType: \"Schwannoma\" is listed. All set. The final JSON should reflect these changes.\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2286,
            "outputTokens": 366,
            "totalTokens": 2652
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "df3a0e72-b95f-4a8b-a300-fddbbcb2ecfa",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:49:54 GMT",
                "content-type": "application/json",
                "content-length": "1711",
                "connection": "keep-alive",
                "x-amzn-requestid": "df3a0e72-b95f-4a8b-a300-fddbbcb2ecfa"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis-NOS\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata curation task. The user wants me to replace broad synonyms with more specific terms from the Target Schema.\n\nFirst, looking at the diagnosis field. The input is \"neurocristopathy\". I need to check the enum list for diagnosis. The term \"neurocristopathy\" isn't there, but I know that schwannomatosis is a type of neurocristopathy. The closest terms in the schema are \"Schwannomatosis-NOS\" (Not Otherwise Specified) or \"Schwannomatosis-NEC\" (Not Elsewhere Classified). Since the input is a general term, \"Schwannomatosis-NOS\" might be the best fit here as a non-specific category.\n\nNext, the assay is \"transcriptomics\". The Target Schema's assay enum includes \"transcriptomics\", so that's already an exact match. No change needed here.\n\nFor tumorType, the input is \"neurolemmoma\". I recall that neurolemmoma is another name for schwannoma. Checking the tumorType enum, \"Schwannoma\" is listed. So replacing \"neurolemmoma\" with \"Schwannoma\" would be correct.\n\nI need to ensure all replacements use the exact terms from the schema. Let me double-check each enum list again to confirm. Diagnosis: \"Schwannomatosis-NOS\" is present. Assay: \"transcriptomics\" is there. TumorType: \"Schwannoma\" is listed. All set. The final JSON should reflect these changes.\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2286,
              "outputTokens": 366,
              "totalTokens": 2652
            },
            "metrics": {
              "latencyMs": 2622
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2286,
          "output_tokens": 366,
          "total_tokens": 2652
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis-NOS\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```Okay, let's tackle this metadata curation task. The user wants me to replace broad terms with specific ones from the Target Schema. Let's start with the diagnosis. The input has \"phakomatosis\". I know that phakomatosis is a broad term that includes conditions like neurofibromatosis and schwannomatosis. Looking at the Target Schema's diagnosis enum, \"Neurofibromatosis type 1\" is an option. Since \"phakomatosis\" is a general term, and the user might be referring to a specific type, but without more context, maybe the safest choice here is \"Schwannomatosis-NOS\" (Not Otherwise Specified) or \"Schwannomatosis-NEC\" (Not Elsewhere Classified). Wait, but \"Neurofibromatosis type 1\" is also a phakomatosis. Hmm. The problem is that \"phakomatosis\" is a group of disorders, so unless there's more info, it's hard to pick the exact one. However, the Target Schema doesn't have \"phakomatosis\" as an option, so I need to choose the closest. Maybe \"Schwannomatosis-NOS\" is better here as a general category.\n\nNext, the assay is \"viability assay\". The Target Schema has \"cell viability assay\" as an enum value. So replacing \"viability assay\" with \"cell viability assay\" makes sense. That's straightforward.\n\nFor tumorType: \"tumor of cranial and spinal nerves\". The Target Schema's tumorType enum includes \"Schwannoma\" which is a tumor of the nerve sheath, typically affecting cranial and spinal nerves. So \"Schwannoma\" would be the specific term here. Alternatively, \"Malignant Peripheral Nerve Sheath Tumor\" if it's malignant, but the input doesn't specify malignancy. Since \"Schwannoma\" is a benign tumor of the nerve sheath, that's the best fit.\n\nSo putting it all together, the corrected entries would be diagnosis: \"Schwannomatosis-NOS\", assay: \"cell viability assay\", tumorType: \"Schwannoma\". Wait, but the diagnosis \"Schwannomatosis-NOS\" is part of the enum. Alternatively, if \"phakomatosis\" is being used as a synonym for Neurofibromatosis type 1, but that's a stretch. Since the Target Schema doesn't have a direct equivalent for phakomatosis, and Schwannomatosis is a type of phakomatosis, maybe \"Schwannomatosis-NOS\" is the best fit here. Alternatively, \"Neurofibromatosis type 1\" if the context is NF1, but without more info, I think \"Schwannomatosis-NOS\" is safer. Alternatively, maybe \"Schwannomatosis\" without the suffix. Let me check the enum again. The diagnosis enum includes \"Schwannomatosis\", \"Schwannomatosis-NOS\", and \"Schwannomatosis-NEC\". Since the original term is very broad, \"Schwannomatosis-NOS\" might be appropriate as a not otherwise specified category. Alternatively, if the user intended a more general term, \"Schwannomatosis\" is also present. But the instruction says to use the exact values. Since \"Schwannomatosis\" is an option, maybe that's better than adding NOS. But I need to consider if \"phakomatosis\" maps directly to any of the options. Since phakomatosis includes NF1, NF2, schwannomatosis, etc., but the input diagnosis is \"phakomatosis\", which isn't in the Target Schema. Therefore, the best approach is to choose the most specific possible term that's a subtype of phakomatosis. However, without additional context, it's ambiguous. The safest choice might be \"Schwannomatosis-NOS\" as a general category when the specific type isn't known. Alternatively, if the tumorType is Schwannoma, which is associated with schwannomatosis, then the diagnosis could be \"Schwannomatosis\". Let me check the tumorType again: \"tumor of cranial and spinal nerves\" maps to \"Schwannoma\", which is a tumor of the nerve sheath. Schwannomatosis is a condition where multiple schwannomas develop. So if the tumorType is Schwannoma, the diagnosis would likely be Schwannomatosis or one of its subtypes. But the original diagnosis is phakomatosis, which is a broader term. Since the Target Schema doesn't have phakomatosis, and the tumor is Schwannoma, the diagnosis should be narrowed to a schwannomatosis-related term. The options are \"Schwannomatosis\", \"Schwannomatosis-NOS\", \"Schwannomatosis-NEC\", \"SMARCB1-related schwannomatosis\", etc. Since there's no info on genetic cause, \"Schwannomatosis-NOS\" would be appropriate. Therefore, diagnosis: \"Schwannomatosis-NOS\", assay: \"cell viability assay\", tumorType: \"Schwannoma\".\n",
          "model_id": "us.deepseek.r1-v1:0",
          "usage": {
            "inputTokens": 2289,
            "outputTokens": 1112,
            "totalTokens": 3401
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "b873a0f8-3fe7-4402-a20e-fc1ebbe8b77a",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 05:50:03 GMT",
                "content-type": "application/json",
                "content-length": "4736",
                "connection": "keep-alive",
                "x-amzn-requestid": "b873a0f8-3fe7-4402-a20e-fc1ebbe8b77a"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis-NOS\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```"
                  },
                  {
                    "reasoningContent": {
                      "reasoningText": {
                        "text": "Okay, let's tackle this metadata curation task. The user wants me to replace broad terms with specific ones from the Target Schema. Let's start with the diagnosis. The input has \"phakomatosis\". I know that phakomatosis is a broad term that includes conditions like neurofibromatosis and schwannomatosis. Looking at the Target Schema's diagnosis enum, \"Neurofibromatosis type 1\" is an option. Since \"phakomatosis\" is a general term, and the user might be referring to a specific type, but without more context, maybe the safest choice here is \"Schwannomatosis-NOS\" (Not Otherwise Specified) or \"Schwannomatosis-NEC\" (Not Elsewhere Classified). Wait, but \"Neurofibromatosis type 1\" is also a phakomatosis. Hmm. The problem is that \"phakomatosis\" is a group of disorders, so unless there's more info, it's hard to pick the exact one. However, the Target Schema doesn't have \"phakomatosis\" as an option, so I need to choose the closest. Maybe \"Schwannomatosis-NOS\" is better here as a general category.\n\nNext, the assay is \"viability assay\". The Target Schema has \"cell viability assay\" as an enum value. So replacing \"viability assay\" with \"cell viability assay\" makes sense. That's straightforward.\n\nFor tumorType: \"tumor of cranial and spinal nerves\". The Target Schema's tumorType enum includes \"Schwannoma\" which is a tumor of the nerve sheath, typically affecting cranial and spinal nerves. So \"Schwannoma\" would be the specific term here. Alternatively, \"Malignant Peripheral Nerve Sheath Tumor\" if it's malignant, but the input doesn't specify malignancy. Since \"Schwannoma\" is a benign tumor of the nerve sheath, that's the best fit.\n\nSo putting it all together, the corrected entries would be diagnosis: \"Schwannomatosis-NOS\", assay: \"cell viability assay\", tumorType: \"Schwannoma\". Wait, but the diagnosis \"Schwannomatosis-NOS\" is part of the enum. Alternatively, if \"phakomatosis\" is being used as a synonym for Neurofibromatosis type 1, but that's a stretch. Since the Target Schema doesn't have a direct equivalent for phakomatosis, and Schwannomatosis is a type of phakomatosis, maybe \"Schwannomatosis-NOS\" is the best fit here. Alternatively, \"Neurofibromatosis type 1\" if the context is NF1, but without more info, I think \"Schwannomatosis-NOS\" is safer. Alternatively, maybe \"Schwannomatosis\" without the suffix. Let me check the enum again. The diagnosis enum includes \"Schwannomatosis\", \"Schwannomatosis-NOS\", and \"Schwannomatosis-NEC\". Since the original term is very broad, \"Schwannomatosis-NOS\" might be appropriate as a not otherwise specified category. Alternatively, if the user intended a more general term, \"Schwannomatosis\" is also present. But the instruction says to use the exact values. Since \"Schwannomatosis\" is an option, maybe that's better than adding NOS. But I need to consider if \"phakomatosis\" maps directly to any of the options. Since phakomatosis includes NF1, NF2, schwannomatosis, etc., but the input diagnosis is \"phakomatosis\", which isn't in the Target Schema. Therefore, the best approach is to choose the most specific possible term that's a subtype of phakomatosis. However, without additional context, it's ambiguous. The safest choice might be \"Schwannomatosis-NOS\" as a general category when the specific type isn't known. Alternatively, if the tumorType is Schwannoma, which is associated with schwannomatosis, then the diagnosis could be \"Schwannomatosis\". Let me check the tumorType again: \"tumor of cranial and spinal nerves\" maps to \"Schwannoma\", which is a tumor of the nerve sheath. Schwannomatosis is a condition where multiple schwannomas develop. So if the tumorType is Schwannoma, the diagnosis would likely be Schwannomatosis or one of its subtypes. But the original diagnosis is phakomatosis, which is a broader term. Since the Target Schema doesn't have phakomatosis, and the tumor is Schwannoma, the diagnosis should be narrowed to a schwannomatosis-related term. The options are \"Schwannomatosis\", \"Schwannomatosis-NOS\", \"Schwannomatosis-NEC\", \"SMARCB1-related schwannomatosis\", etc. Since there's no info on genetic cause, \"Schwannomatosis-NOS\" would be appropriate. Therefore, diagnosis: \"Schwannomatosis-NOS\", assay: \"cell viability assay\", tumorType: \"Schwannoma\".\n"
                      }
                    }
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2289,
              "outputTokens": 1112,
              "totalTokens": 3401
            },
            "metrics": {
              "latencyMs": 9275
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2289,
          "output_tokens": 1112,
          "total_tokens": 3401
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4333333333333334,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 76.75304961204529,
    "token_usage": {
      "input_tokens": 22847,
      "output_tokens": 9106,
      "total_tokens": 31953
    }
  }
}